Skip to main content

Revision Bulletins

Revision Bulletins are published in USP–NF Online by the first of each month. Each Revision Bulletin includes a notice that provides the reason for the change and the official date. Monograph names listed before April 1, 2021 contain a combined notice and documentary standard; postings after April 1, 2021 provide separate links for the notice and for the standard content. For more information on the Revision Bulletins and the Accelerated Revision process, see USP's Guideline on the Use of Accelerated Processes for Revisions to USP–NF. Archived Revision Bulletins can be found here.

See the Publication & Comment Schedule section for specific posting and official dates.

New and Updated Revision Bulletins

  • Digoxin Tablets Notice and Monograph (posted 24-Jun-2022; official 01-Jul-2022)
  • Mexiletine Hydrochloride Capsules Notice and Monograph (posted 24-Jun-2022; official 01-Jul-2022)
  • Mitotane Notice and Monograph (posted 24-Jun-2022; official 01-Aug-2023)
  • Mitotane Tablets Notice and Monograph (posted 24-Jun-2022; official 01-Aug-2023)
  • Terazosin Capsules Notice and Monograph (posted 24-Jun-2022; official 01-Jul-2022)
  • Levetiracetam Tablets Notice and Monograph (posted 15-Jun-2022; official 16-Jun-2022)
    • Previously Published as a Pending Revision
  • Azithromycin for Oral Suspension Notice and Monograph (posted 27–May–2022; official 01–Jun–2022)
  • Diethylene Glycol Stearates Notice and Monograph (posted 27–May–2022; official 01–Jun–2022)
  • Guanfacine Extended-Release Tablets Notice and Monograph (posted 27–May–2022; official 01–Jun–2022)
  • Hydroxychloroquine Sulfate Tablets Notice and Monograph (posted 27–May–2022; official 01–Jun–2022)
  • Levothyroxine Sodium Tablets Notice and Monograph (posted 27–May–2022; official 01–Jun–2022)
  • Loratadine Capsules Notice and Monograph (posted 27–May–2022; official 01–Jun–2022)
  • Methylprednisolone Tablets Notice and Monograph (posted 27–May–2022; official 01–Jun–2022)
  • Potassium Citrate Extended-Release Tablets Notice and Monograph (posted 27–May–2022; official 01–Jun–2022)
  • Abiraterone Acetate Tablets Notice and Monograph (posted 04–May–2022; official 05–May–2022)
    • Previously posted as a Pending Revision
  • Methylprednisolone Sodium Succinate for Injection Notice and Monograph (posted 04–May–2022; official 05–May–2022) 
    • Previously posted as a Pending Revision
  • <665> Plastic Components and Systems Used to Manufacture Pharmaceutical Drug Products and Biopharmaceutical Drug Substances and Products Notice and Chapter (posted 29-Apr-2022; official 01-May-2026)
  • Acyclovir Notice and Monograph (posted 29-Apr-2022; official 01-May-2023)
  • Calcipotriene Ointment Notice and Monograph (posted 29-Apr-2022; official 01-Aug-2022)
  • Carbidopa and Levodopa Orally Disintegrating Tablets Notice and Monograph (posted 29-Apr-2022; official 01-May-2022)
  • Dextrose Injection Notice and Monograph (posted 29-Apr-2022; official 01-Jun-2022)
  • Fondaparinux Sodium Notice and Monograph (posted 29-Apr-2022; official 01-Aug-2022)
  • Vancomycin Injection Notice and Monograph (posted 29-Apr-2022; official 01-May-2022)
  • Metolazone Tablets Notice and Monograph (posted 14–Apr–2022; official 15–Apr–2022)
    • Previously published as a Pending Revision

Revision Bulletins

To view Accelerated Revisions by official date, please click here.